Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches A. J. SchraderZ. VargaR. Hofmann Review 25 November 2005 Pages: 137 - 149
Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines Megumi SenjuNaoko SueokaEisaburo Sueoka Original Paper 09 November 2005 Pages: 150 - 158
MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients Linnea M. BaudhuinLewis R. RobertsW. Edward Highsmith Original Paper 15 November 2005 Pages: 159 - 162
Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer Annette Schmider-RossOlaf PirsigAngela Reles Original Paper 19 November 2005 Pages: 163 - 170
Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells Nagathihalli S. NagarajNadarajah VigneswaranWolfgang Zacharias Original Paper 16 December 2005 Pages: 171 - 183
Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells Joong-Won ParkJung Eun ParkChang-Min Kim Original Paper 06 December 2005 Pages: 184 - 192
Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population Jing JiangJingweng WangShinkan Tokudome Original Paper 03 December 2005 Pages: 193 - 199
Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms Tamara ČačevMladen JokićSanja Kapitanović Original Paper 08 November 2005 Pages: 200 - 204